高飞

学习&教育：

中山大学肿瘤学博士、美国Rochester大学博士后

　　2003年毕业于中山大学医学院留校在附属肿瘤医院工作至今。2014年5月至2015年8月美国Rochester大学医学中心访问学者，获Research Fellowship。从事肿瘤微创介入治疗20余年,在肝癌合并门静脉高压症微创介入治疗（尤其疑难门静脉高压症TIPS术、复杂门静脉闭塞性疾病介入开通）、实体肿瘤射频（微波）消融及粒子植入、复杂恶性梗阻性黄疸胆道支架植入及腔内近距离治疗等方面具有丰富的临床经验。作为发起人与执行主席连续主办八届“南方TIPS论坛”。主张肝癌合并门静脉高压症的积极干预，以期改善患者生活质量与预后、提高生存。以通讯或第一作者在《Radiology》、《Eur Radiol》等国际知名杂志发表论文60余篇。主持国家自然科学基金面上项目、广东省自然科学基金等十余项课题研究，发明专利3项。国际交流：APSCVIR 2018、APSCVIR 2019 APSCVIR 2021、APSCVIR 2022（第13、14、15、16届亚太介入年会口头报告、第51届日本介入年会口头报告）、 CIRSE 2019、CIRSE 2022 （2019、2022年欧洲介入年会口头报告）、SIR 2019 （2019年美国介入年会口头报告）。参编“中国经颈静脉肝内门体分流术（TIPS）临床实践指南（2019年版）”及“经颈静脉肝内门体静脉分流术治疗门静脉高压专家共识（2022年版） ”。

获奖：
中国抗癌协会科技进步二等奖（第三）

广东省科技进步一等奖（第七）

首届国之名医•青年新锐

2019年中国介入新锐

Research Fellowship of URMC (USA)

2019年中国静脉介入新锐

2019年中华介入明日之星

广东最具实力的中青年医师

2015年全国优秀青年介入医师研究奖二等奖

第十六届全国放射性粒子治疗肿瘤学术大会优秀论文一等奖

首届中山大学肿瘤防治中心微创手术视频大赛一等奖（微创介入组）

主要学术兼职：
中国医师协会介入医师分会青年副主任委员

白求恩基金会介入诊疗专委会副主任委员

国家卫健委能建中心介入专委会门脉高压学组副组长

中国抗癌协会肿瘤微创治疗专业委员会常委&青年副主任委员

中国抗癌协会肿瘤介入专业委员会青年副主任委员

广东省抗癌协会肿瘤微创治疗专业委员会候任主任委员

广东省医学会介入医学分会青年副主任委员

部分通讯及第一作者论文：

1. Wenliang Zhu#, Zhenkang Qiu#, Huzheng Yan, Zhihui Zhong, Weiwei Jiang, Fujun Zhang,* and Fei Gao* .Retrograde venous coil embolization prior to transarterial chemoembolization in hepatocellular carcinoma with arterio-hepatic venous shunts. Diagn Interv Radiol. 2022 28(6): 616–620.
2. Huzheng Yan#, Zhenkang Qiu#, Zhanwang Xiang, Kai Feng, Mingsheng Huang*, Fei Gao*. TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experience. Cancer Imaging. 2022; 22: 13. 
3. Zhenkang Qiu#, Wenliang Zhu#, Huzheng Yan, Guobao Wang, Mengxuan Zuo, Han Qi, Guisong Wang, Weiwei Jiang, Jingbing Xue, Fujun Zhang*, Fei Gao*. Single-Centre Retrospective Study Using Propensity Score Matching Comparing Left Versus Right Internal Jugular Vein Access for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation. Cardiovasc Intervent Radiol. 2022; 45(5): 563–569.
4. Zhenkang Qiu#, Guobao Wang#, Guang Yang, Guisong Wang, Weiwei Jiang, Zixiong Chen, Wenliang Zhu, Huanqing Guo, Fujun Zhang*, Fei Gao*. Transcriptome sequencing-based personalized analysis of hepatocellular carcinoma patients with portal vein tumor thrombus. J Gastrointest Oncol. 2021 Apr; 12(2): 795–805. 
5. Zixiong Chen#, Xiaobo Fu#, Zhenkang Qiu, Maoyuan Mu, Weiwei Jiang, Guisong Wang, Zhihui Zhong, Han Qi*, Fei Gao*. CT-guided 125I Brachytherapy for Hepatocellular Carcinoma in High-risk Locations after Transarterial Chemoembolization Combined with Microwave Ablation: A Propensity Score-matched Study Radiol Oncol. 2023 Mar; 57(1): 127–139. 
6. Zhenkang Qiu#, Guobao Wang#, Huzheng Yan, Han Qi, Mengxuan Zuo, Guisong Wang, Weiwei Jiang, Zixiong Chen, Jingbing Xue, Ligong Lu, Fujun Zhang*, Fei Gao*. TIPS plus sequential systemic therapy of advanced HCC patients with tumour thrombus-related symptomatic portal hypertension. Eur Radiol. 2022; 32(10): 6777–6787. 
7. Huzheng Yan#, Guobao Wang#, Wenliang Zhu, Kai Feng, Wenke Zhu, Xuan Wu, Zhenkang Qiu, Guanyu Chen, Weiwei Jiang, Fujun Zhang*, Fei Gao*. Feasibility and clinical value of TIPS combined with subsequent antitumor treatment in HCC patients with refractory ascites. Transl Oncol. 2020 Dec; 13(12): 100864. 
8. Huzheng Yan#, Ma Luo#, Lifei Wang, Zhenkang Qiu, Zhiqiang Mo, Zhanwang Xiang, Yanling Zhang, Guanyu Chen, Zhihui Zhong, Xiuchen Wang, Fei Gao*, Fujun Zhang*. Clinical efficacy and prognostic factors of CT-guided 125I brachytherapy for the palliative treatment of retroperitoneal metastatic lymph nodes. Cancer Imaging. 2020; 20:25. 
9. Zhenkang Qiu, Gui Song Wang, Fei Gao. Whole-course management of interventional treatment in liver cancer patients with portal hypertension J Interv Med. 2019 May; 2(2): 52–54.Correction in: J Interv Med. 2020 Dec; 3(4): 216.
10. Xiaobo Fu#, Weiwei Jiang#, Maoyuan Mu, Guobao Wang, Han Qi, Zixiong Chen, Mengxuan Zuo*, Fei Gao*. Effect of percutaneous stenting strategy of unresectable malignant hilar biliary obstruction by three‐dimensional reconstruction volumetry. Cancer Med. 2023 Apr; 12(8): 9506–9516.
11. Ye Sheng#, Xiaobo Fu#, Guobao Wang, Maoyuan Mu, Weiwei Jiang, Zixiong Chen, Han Qi*, Fei Gao*. Safety and efficacy of self-expandable metallic stent combined with 125I brachytherapy for the treatment of malignant obstructive jaundice. Cancer Imaging. 2023; 23: 33. 
12. Wang G, Zhang F, Yang B, Xue J, Peng S, Zhong Z, Zhang T, Lu M, Gao F*.   Feasibility and Clinical Value of CT-guided (125)I Brachytherapy for Bilateral Lung Recurrences from Colorectal Carcinoma. Radiology. 2016 Mar;278(3):897-905.
13. Mo Z#, Zhang T#, Zhang Y, Xiang Z, Yan H, Zhong Z, Gao F*, Zhang  F*.   Feasibility  and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure. Eur Radiol. 2018 Mar;28(3):1194-1203.
14. Yan H#, Xiang Z#, Zhong Z#, Mo Z, Zhang T, Chen G, Zhang F*, Gao F*. CT-guided 125I brachytherapy in the treatment of distant metastases in the oral cavity and maxillofacial region. Transl Oncol. 2017 Feb;10(1):90-98.
15. Yan H#, Mo Z#, Xiang Z, Rong D, Zhang Y, Chen G, Zhong Z, Zhang F*, Gao F*. CT-guided 125I brachytherapy for locally recurrent nasopharyngeal carcinoma. J Cancer. 2017 Jul 5;8(11):2104-2113.
16. Xiang Z#, Mo Z#, Li G#, Gilani S, Zhong Z, Zhang T, Zhang F*, Gao F*. 125I brachytherapy in the palliation of painful bone metastases from lung cancer after failure or rejection of conventional treatments. Oncotarget. 2016 Apr 5;7(14):18384-93.
17. Gao F, Li C, Gu Y, Huang J, Wu P. CT-guided 125I brachytherapy for mediastinal metastatic lymph nodes recurrence from esophageal carcinoma: effectiveness and safety in 16 patients. Eur J Radiol 2013; 82(2):e70-75.
18. Zhang T#, Lu M#, Peng S, Zhang W, Yang G, Liu Z, Singh S, Yang Y, Zhang F*, Gao F*. CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy. J Cancer Res Clin Oncol 2014;140(8):1383-1390.
19. Yang G#, Peng S#, Zhang Y, Liu Z, Lu M, Zhang T, Gao F*, Zhang F*. Cell-based assay system to estimate the effect of 125I seeds on cancer cells: effect of osteopontin. Recent Pat Anticancer Drug Discov 2014; 9(2):258-263.
20. Yang G#, Zhang S#, Gao F#, Liu Z, Lu M, Peng S, Zhang T, Zhang F. 
    Osteopontin enhances the expression of HOTAIR in cancer cells via IRF1. Biochim Biophys Acta. 2014; 1839(9):837-848.  
21. Gao F, Gu YK, Huang JH, Zhao M, Wu PH*. Radiofrequency Ablation of Retroperitoneal Metastatic Lymph Nodes from Hepatocellular Carcinoma, Acad Radiol; 2012; 19(8):1035-1040.
22.  Gao F, Gu YK, Fan WJ, Zhang L, Huang JH*, Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol; 2011; 17(26):3145-3150.  
23.  Gao F, Gu YK, Shen JX, Li CL, Jiang XY, Huang JH*, Experimental study of  destruction to porcine spleen in vivo by microwave ablation. World J Gastroenterol; 2011; 17(45):5014-5020.
24. Gao F#, Zhong R#, Li GH, Zhang WD*. Computed tomography and magnetic  resonance imaging findings of inflammatory myofibroblastic tumors of the head  and neck. Acta Radiol, 2014; 55(4):434-440.  
25. Gao F, He N, Wu PH*. The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancer. Chin J   2014, 33(11):569-73.
26. Gao F#, Wang GB#, Xiang ZW#, Yang B, Xue JB, Mo ZQ, Zhong ZH, Zhang T, Zhang FJ *, Fan WJ *. A preoperative mathematic model for computed tomographic guided microwave ablation treatment of hepatic dome tumors. Oncotarget. 2016 May 3;7(18):25949-25959.
27. Liu Z#, Gao F#, Yang G, Singh S, Lu M, Zhang T, Zhong  Z, Zhang F, Tang R. Combination of radiofrequency ablation with transarterial  chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis. Tumour Biol, 2014; 35(8):7407-7413.  
28.  Jingxian Shen, Fei Gao*, Jing Zhao, Yunxian Mo, Peihong Wu. Small hepatocellular carcinoma keeping hypodense during dual phase helical CT scan and correlative pathology, J Biomed Graph Comput, 2013; 3(4):1-7. 
29. Yongxin Chen, Fei Gao*, Lin Chen, Sheng Peng, Yingjie Huang, Yao Wang. Effectiveness and Safety of CT-Guided 125I Brachytherapy for Lung Metastasis from Hepatocellular Carcinoma. Open Journal of Radiology, 2013; 3:159-164. 
30. Zhanwang Xiang#, Lifei Wang#, Huzheng Yan, Zhihui Zhong, Wangkai Liu, Zhiqiang Mo, Fei Gao*, Fujun Zhang*. 125I seed brachytherapy versus external beam radiation therapy for the palliation of painful bone metastases of lung cancer after one cycle of chemotherapy progression. Oncotarget and Therapy, 2018,11:5183-5193.

更新日期：2023年8月1日